Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Mills, Inc. (GIS) vs Eli Lilly And Co (LLY) Price & Performance

General Mills, Inc.Trade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

General Mills, Inc. vs Eli Lilly And Co — how do they compare? General Mills, Inc. trades at $38.24 (market cap $20.24B), while Eli Lilly And Co trades at $1,218.8 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 53.4× General Mills, Inc.'s market cap, and General Mills, Inc. pays the higher dividend (6.43%). Which is the better fit depends on your goals.

GISLLY
Market Cap
$20.24B$1.08T
Sector
Consumer StaplesHealth
52-Week High
$51.11$1.24K
52-Week Low
$32.17$639.43
Enterprise Value
$33.73B$1.13T
Dividend Yield
6.43%0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Mills, Inc.

General Mills (GIS) trades at $37.97, up 1.89% today, showing a mixed technical picture with a bullish moving average signal but a neutral RSI. Fundamentally, the company reported a net loss in 2026, compressing margins, though it beat Q2 2026 EPS estimates. Recent news highlights strategic partnerships in regenerative agriculture and new product launches to drive growth amid challenging consumer demand.

The outlook is cautious; while the stock appears undervalued on a P/E basis and offers a dividend, significant risks include persistent margin pressure, high debt levels, and weak sales growth. Analyst consensus is predominantly Hold, reflecting uncertainty about the company's turnaround efforts in a competitive market.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.

LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About General Mills, Inc.

General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.

Read more on GIS

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY